Increased potency and functional persistence in vitro of a next-generation ny-eso-1-specific tcr therapy incorporating gen-r-tm genetic reprogramming technology Helle Jensen , Rachel Fukuda , Megan Murt , Xiao Wang , Lora Zhao , Sheila Lou , Purnima Sundar , Christopher Navas , Andrew Jimena , Amanda Sims , Travis Beckett , Shobha Potluri , Rowena Martinez , David Chian , Candace Sims , Quinn Walker , Abira Bandyopadhyay , Breanna Pamintuan , Bijan Boldajipour , Chang-Chih Wu , Martin Wohlfahrt , Byoung Ryu , Viola C. Lam , Rachel C. Lynn , Hajime Hiraragi , Johannes Breuning , Ashley Hamilton , Fotini Kouri , Jack Euesden , Sara Brett , Blythe Sather JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
